GSK Third-Quarter Shingrix Sales Fall 5% to GBP780M
GSK reported Shingrix sales of GBP780 million in the third quarter, down 5% at constant currency.
Related stories
Proto Labs Shares Fall 7.6% After Q3 Results and Q4 Guidance
Proto Labs shares were down 7.6% in early Thursday trading. The headline reports higher Q3 adjusted earnings and revenue and that Q4 guidance was set.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Bank of Jordan Q3 Profit Attributable to Shareholders Is 9.8 Million Dinars
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Alamos Gold Q3 2026 Earnings Call Begins
Alamos Gold's quarterly earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
NWPX Infrastructure Q3 2026 Earnings Call Begins
NWPX Infrastructure's Q3 2026 earnings call has begun.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Quanta Services Rises on Optimistic Outlook and Q3 Results
Quanta Services shares rose after the company reported third-quarter results above expectations and an optimistic outlook.
M impact | EQUITY | Oct 29, 2026, 01:57 PM UTC
Jiangxi Zhengbang Tech Reports Q3 Net Loss of 353.8 Million Yuan
Jiangxi Zhengbang Tech reported a net loss of 353.8 million yuan for the third quarter.
M impact | EQUITY | Oct 29, 2026, 01:56 PM UTC